- L-Carnitine plus cilostazol versus cilostazol alone for the treatment of claudication in patients with peripheral artery disease: a multicenter, randomized, double-blind, placebo-controlled trialNeil A Goldenberg
Department of Medicine, Division of Hematology, University of Colorado School of Medicine, Aurora, CO 80045, USA
Vasc Med 17:145-54. 2012..145 for cilostazol/placebo (p = 0.048). QOL measures were also improved in the cilostazol/l-carnitine group. These findings support larger trials of l-carnitine in combination with cilostazol in the treatment of IC...